Page last updated: 2024-10-21

amitrole and Deafness, Transitory

amitrole has been researched along with Deafness, Transitory in 1 studies

Amitrole: A non-selective post-emergence, translocated herbicide. According to the Seventh Annual Report on Carcinogens (PB95-109781, 1994) this substance may reasonably be anticipated to be a carcinogen. (From Merck Index, 12th ed) It is an irreversible inhibitor of CATALASE, and thus impairs activity of peroxisomes.
amitrole : A member of the class of triazoles that is 1H-1,2,4-triazole substituted by an amino group at position 3. Used to control annual grasses and aquatic weeds (but not on food crops because it causes cancer in laboratory animals). Its use within the EU was banned from September 2017 on the grounds of potential groundwater contamination and risks to aquatic life; there have also been concerns about its endocrine-disrupting properties.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Lee, JN1
Kim, SG1
Lim, JY1
Dutta, RK1
Kim, SJ1
Choe, SK1
So, HS1
Park, R1

Other Studies

1 other study available for amitrole and Deafness, Transitory

ArticleYear
3-Aminotriazole protects from CoCl2-induced ototoxicity by inhibiting the generation of reactive oxygen species and proinflammatory cytokines in mice.
    Archives of toxicology, 2016, Volume: 90, Issue:4

    Topics: Amitrole; Animals; Catalase; Cell Line; Cobalt; Hair Cells, Auditory; Hearing Loss; Mice, Inbred BAL

2016